George Wilson is the Assistant Director of New Venture Programs at Vanderbilt University. He manages several programs and pipelines that commercialize Vanderbilt’s intellectual property via startups. Supporting both the University and its Medical Center, he previously spent a decade as a biomedical researcher and operations lead of a preclinical CRO. He holds a BA in Clinical Neuroscience and an MS in Pharmacology from Vanderbilt, an MS in Finance from Purdue Global University, and is completing an MLS from Vanderbilt Law School.